important consideration development effective strategies radioimmunotherapy nature radiation emitted radionuclide radionuclides decaying emission offer possibility matching cell specific reactivity monoclonal antibodies radiation range cell diameters furthermore important biological advantages compared external beam radiation including higher biological effectiveness nearly independent oxygen concentration dose rate cell cycle position review clinical settings likely benefit radioimmunotherapy discussed current status preclinical clinical research antibodies labeled NUMBER promising emitting radionuclides 213bi 225ac 211at summarized references NUMBER alpha particles alpha particles beta particles alpha particle alpha particle